Parametric insurance is becoming an important part of the solution
Key Takeaways GLP-1 receptor agonists, including Tirzepatide, Semaglutide, and Liraglutide, are effective in promoting weight loss and improving glycemic control, with varying degrees of effectiveness and administration schedules
Selecting the optimal choice depends on skin type, objectives, and downtime tolerance
Use of JARDIANCE for this indication is supported by evidence from a 26-week double-blind, placebo-controlled clinical trial, with a double-blind active treatment safety extension period of up to 52 weeks in 157 pediatric patients aged 10 to 17 years with type 2 diabetes mellitus and a pediatric pharmacokinetic study [see Clinical Pharmacology (12.3) and Clinical Studies (14.2)]
Enhancing melanin production offers a natural-looking tan without the harmful effects of UV exposure
As we get older, wrinkles and signs of aging reflect back to us in the mirror
